• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自噬调控作为骨肉瘤潜在治疗策略的研究进展。

Autophagy Modulation as a Potential Therapeutic Strategy in Osteosarcoma: Current Insights and Future Perspectives.

机构信息

Yeast Physiology Group, Departamento de Genética y Microbiología, Facultad de Biología, Universidad de Murcia, 30100 Murcia, Spain.

出版信息

Int J Mol Sci. 2023 Sep 7;24(18):13827. doi: 10.3390/ijms241813827.

DOI:10.3390/ijms241813827
PMID:37762129
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10531374/
Abstract

Autophagy, the process that enables the recycling and degradation of cellular components, is essential for homeostasis, which occurs in response to various types of stress. Autophagy plays an important role in the genesis and evolution of osteosarcoma (OS). The conventional treatment of OS has limitations and is not always effective at controlling the disease. Therefore, numerous researchers have analyzed how controlling autophagy could be used as a treatment or strategy to reverse resistance to therapy in OS. They highlight how the inhibition of autophagy improves the efficacy of chemotherapeutic treatments and how the promotion of autophagy could prove positive in OS therapy. The modulation of autophagy can also be directed against OS stem cells, improving treatment efficacy and preventing cancer recurrence. Despite promising findings, future studies are needed to elucidate the molecular mechanisms of autophagy and its relationship to OS, as well as the mechanisms underlying the functioning of autophagic modulators. Careful evaluation is required as autophagy modulation may have adverse effects on normal cells, and the optimization of autophagic modulators for use as drugs in OS is imperative.

摘要

自噬是一种使细胞成分回收和降解的过程,对于维持内稳态至关重要,内稳态是对各种类型的应激的反应。自噬在骨肉瘤(OS)的发生和发展中起着重要作用。OS 的传统治疗方法存在局限性,并不总是能有效地控制疾病。因此,许多研究人员分析了如何控制自噬可以作为治疗或逆转 OS 治疗耐药性的策略。他们强调了自噬抑制如何提高化疗治疗的疗效,以及自噬促进如何在 OS 治疗中证明是积极的。自噬的调节也可以针对 OS 干细胞,提高治疗效果并预防癌症复发。尽管有有希望的发现,但仍需要进一步的研究来阐明自噬的分子机制及其与 OS 的关系,以及自噬调节剂作用的机制。需要仔细评估,因为自噬调节可能对正常细胞产生不良影响,并且优化自噬调节剂作为 OS 药物的使用是至关重要的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67de/10531374/0a7b0372cc1b/ijms-24-13827-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67de/10531374/34ea0ffc26d9/ijms-24-13827-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67de/10531374/5a3f014c62ae/ijms-24-13827-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67de/10531374/93832d303e5d/ijms-24-13827-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67de/10531374/b567215ffb1d/ijms-24-13827-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67de/10531374/7797280e1b1e/ijms-24-13827-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67de/10531374/0a7b0372cc1b/ijms-24-13827-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67de/10531374/34ea0ffc26d9/ijms-24-13827-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67de/10531374/5a3f014c62ae/ijms-24-13827-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67de/10531374/93832d303e5d/ijms-24-13827-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67de/10531374/b567215ffb1d/ijms-24-13827-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67de/10531374/7797280e1b1e/ijms-24-13827-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67de/10531374/0a7b0372cc1b/ijms-24-13827-g005.jpg

相似文献

1
Autophagy Modulation as a Potential Therapeutic Strategy in Osteosarcoma: Current Insights and Future Perspectives.自噬调控作为骨肉瘤潜在治疗策略的研究进展。
Int J Mol Sci. 2023 Sep 7;24(18):13827. doi: 10.3390/ijms241813827.
2
Cytoprotective role of autophagy during paclitaxel-induced apoptosis in Saos-2 osteosarcoma cells.自噬在紫杉醇诱导 Saos-2 骨肉瘤细胞凋亡过程中的细胞保护作用。
Int J Oncol. 2013 Jun;42(6):1985-92. doi: 10.3892/ijo.2013.1884. Epub 2013 Apr 5.
3
The COPS3-FOXO3 positive feedback loop regulates autophagy to promote cisplatin resistance in osteosarcoma.COPS3-FOXO3 正反馈回路调节自噬以促进骨肉瘤对顺铂的耐药性。
Autophagy. 2023 Jun;19(6):1693-1710. doi: 10.1080/15548627.2022.2150003. Epub 2022 Nov 30.
4
CXCR4 blockade sensitizes osteosarcoma to doxorubicin by inducing autophagic cell death via PI3K‑Akt‑mTOR pathway inhibition.CXCR4 阻断通过抑制 PI3K-Akt-mTOR 通路诱导自噬性细胞死亡使骨肉瘤对多柔比星敏感。
Int J Oncol. 2021 Jul;59(1). doi: 10.3892/ijo.2021.5229. Epub 2021 Jun 3.
5
Targeting autophagy is a promising therapeutic strategy to overcome chemoresistance and reduce metastasis in osteosarcoma.靶向自噬是克服骨肉瘤化疗耐药和降低转移的一种有前途的治疗策略。
Int J Oncol. 2019 Dec;55(6):1213-1222. doi: 10.3892/ijo.2019.4902. Epub 2019 Oct 18.
6
Autophagy and its role in osteosarcoma.自噬及其在骨肉瘤中的作用。
Cancer Med. 2023 Mar;12(5):5676-5687. doi: 10.1002/cam4.5407. Epub 2023 Feb 15.
7
Autophagy regulation by microRNAs: Novel insights into osteosarcoma therapy.微小 RNA 对自噬的调控:骨肉瘤治疗的新视角。
IUBMB Life. 2020 Jul;72(7):1306-1321. doi: 10.1002/iub.2277. Epub 2020 Mar 31.
8
LncRNA Sox2OT-V7 promotes doxorubicin-induced autophagy and chemoresistance in osteosarcoma via tumor-suppressive miR-142/miR-22.长链非编码 RNA Sox2OT-V7 通过肿瘤抑制 miR-142/miR-22 促进骨肉瘤多柔比星诱导的自噬和化疗耐药。
Aging (Albany NY). 2020 Apr 16;12(8):6644-6666. doi: 10.18632/aging.103004.
9
HSP90AA1-mediated autophagy promotes drug resistance in osteosarcoma.HSP90AA1 介导的自噬促进骨肉瘤的耐药性。
J Exp Clin Cancer Res. 2018 Aug 28;37(1):201. doi: 10.1186/s13046-018-0880-6.
10
Non‑covalent proteasome inhibitor PI‑1840 induces apoptosis and autophagy in osteosarcoma cells.非共价蛋白酶体抑制剂 PI-1840 诱导骨肉瘤细胞凋亡和自噬。
Oncol Rep. 2019 May;41(5):2803-2817. doi: 10.3892/or.2019.7040. Epub 2019 Mar 1.

引用本文的文献

1
The Role of Autophagy in HIV Infection and Immunological Recovery of ART-Treated PLWH.自噬在接受抗逆转录病毒治疗的艾滋病毒感染者的艾滋病毒感染及免疫恢复中的作用
Viruses. 2025 Jun 23;17(7):884. doi: 10.3390/v17070884.
2
Trends and future directions of autophagy in osteosarcoma: A bibliometric analysis.骨肉瘤中自噬的研究趋势与未来方向:一项文献计量分析
Open Med (Wars). 2024 Dec 3;19(1):20241080. doi: 10.1515/med-2024-1080. eCollection 2024.
3
Global research trends and hotspots in metabolomics of osteosarcoma: a decade-spanning bibliometric and visualized analysis.

本文引用的文献

1
The role of autophagy in bone metabolism and clinical significance.自噬在骨代谢中的作用及其临床意义。
Autophagy. 2023 Sep;19(9):2409-2427. doi: 10.1080/15548627.2023.2186112. Epub 2023 Mar 8.
2
Construction and validation of a prognostic model for osteosarcoma patients based on autophagy-related genes.基于自噬相关基因构建和验证骨肉瘤患者的预后模型
Discov Oncol. 2022 Dec 31;13(1):146. doi: 10.1007/s12672-022-00608-9.
3
Membrane curvature sensing and stabilization by the autophagic LC3 lipidation machinery.自噬 LC3 脂质化机制感知和稳定膜曲率。
全球骨肉瘤代谢组学研究趋势和热点:十年跨度的文献计量学和可视化分析。
Front Immunol. 2024 Oct 9;15:1463078. doi: 10.3389/fimmu.2024.1463078. eCollection 2024.
4
Single-cell RNA sequencing reveals the communications between tumor microenvironment components and tumor metastasis in osteosarcoma.单细胞 RNA 测序揭示骨肉瘤肿瘤微环境成分与肿瘤转移之间的通讯。
Front Immunol. 2024 Sep 11;15:1445555. doi: 10.3389/fimmu.2024.1445555. eCollection 2024.
5
UBE2L3 Suppresses Oxidative Stress-regulated Necroptosis to Accelerate Osteosarcoma Progression.UBE2L3抑制氧化应激调节的坏死性凋亡以加速骨肉瘤进展。
Recent Pat Anticancer Drug Discov. 2025;20(1):102-112. doi: 10.2174/0115748928297557240212112531.
Sci Adv. 2022 Dec 14;8(50):eadd1436. doi: 10.1126/sciadv.add1436.
4
An overview of resistance to chemotherapy in osteosarcoma and future perspectives.骨肉瘤化疗耐药概述及未来展望。
Cancer Drug Resist. 2022 Jun 23;5(3):762-793. doi: 10.20517/cdr.2022.18. eCollection 2022.
5
LncRNA FGD5-AS1 potentiates autophagy-associated doxorubicin resistance by regulating the miR-154-5p/WNT5A axis in osteosarcoma.长链非编码 RNA FGD5-AS1 通过调控 miR-154-5p/WNT5A 轴增强骨肉瘤细胞自噬相关阿霉素耐药性。
Cell Biol Int. 2022 Nov;46(11):1937-1946. doi: 10.1002/cbin.11889. Epub 2022 Aug 30.
6
Traditional Medicinal Plants as a Source of Inspiration for Osteosarcoma Therapy.传统药用植物作为骨肉瘤治疗的灵感来源。
Molecules. 2022 Aug 6;27(15):5008. doi: 10.3390/molecules27155008.
7
Origin and Therapies of Osteosarcoma.骨肉瘤的起源与治疗
Cancers (Basel). 2022 Jul 19;14(14):3503. doi: 10.3390/cancers14143503.
8
miR-29a-3p mitigates the development of osteosarcoma through modulating IGF1 mediated PI3k/Akt/FOXO3 pathway by activating autophagy.miR-29a-3p 通过激活自噬来调节 IGF1 介导的 PI3k/Akt/FOXO3 通路,从而减轻骨肉瘤的发展。
Cell Cycle. 2022 Sep;21(18):1980-1995. doi: 10.1080/15384101.2022.2078614. Epub 2022 May 31.
9
Baicalin induces apoptosis and autophagy in human osteosarcoma cells by increasing ROS to inhibit PI3K/Akt/mTOR, ERK1/2 and β-catenin signaling pathways.黄芩苷通过增加活性氧来抑制PI3K/Akt/mTOR、ERK1/2和β-连环蛋白信号通路,从而诱导人骨肉瘤细胞凋亡和自噬。
J Bone Oncol. 2022 Feb 1;33:100415. doi: 10.1016/j.jbo.2022.100415. eCollection 2022 Apr.
10
Anticancer activity of Germacrone terpenoid in human osteosarcoma cells is mediated via autophagy induction, cell cycle disruption, downregulating the cell cycle regulatory protein expressions and cell migration inhibition.倍半萜吉马酮通过诱导自噬、破坏细胞周期、下调细胞周期调控蛋白表达和抑制细胞迁移来抑制人骨肉瘤细胞的抗癌活性。
Acta Biochim Pol. 2022 Apr 25;69(2):305-308. doi: 10.18388/abp.2020_5712.